Moderate riskFDA DrugClass II

Fresenius Kabi sodium chloride injection recalled for sterility assurance

Fresenius Kabi is recalling one batch of 0.45% sodium chloride injection (saline solution) used in hospitals and medical facilities because the manufacturer cannot guarantee the product is sterile. The affected batch is #6402413 with an expiration date of 02/29/2028. No infections or injuries have been reported so far.

From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls

What to do

  1. If you work in a hospital or medical facility, stop using batch #6402413 immediately.
  2. Contact Fresenius Kabi or your medical supplier about returning the affected product.
  3. Report any use of this batch to your healthcare provider or pharmacist.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 63323-626-03, Unit of Sale NDC Number: 63323-626-25 (30 bags in 1 case).
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 14 products — see all of them.

Details

Illnesses reported
None reported
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Classification
Class II
Recall number
D-0424-2026

In the FDA's words

Description
0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 63323-626-03, Unit of Sale NDC Number: 63323-626-25 (30 bags in 1 case). Lack of Assurance of Sterility Batch # 6402413, Exp Date: 02/29/2028 Distribution: US Nationwide , Alaska, and Puerto Rico.
Hazard
Lack of Assurance of Sterility

14 products in this recall

Fresenius Kabi IV saline and dextrose bags recalled over sterility

Fresenius Kabi is recalling 14 sodium chloride and dextrose IV fluid bags because the company cannot assure they are sterile. The products were sold under the Fresenius Kabi, BD and Fresenius Medical Care names and were distributed nationwide, to Alaska and to Puerto Rico. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Fresenius Kabi

See all

Related topics

SterilityDrugsSold nationwideMore from FDA Drug